Onco Hematology clinical trials

Explore recruiting onco hematology clinical trials.

Recruiting onco hematology studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Onco Hematology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethasone for relapsed multiple myeloma (CONFIRM)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Onco Hematology trials by city

Onco Hematology in Toronto Onco Hematology in Vancouver Onco Hematology in Montreal Onco Hematology in Calgary Onco Hematology in Edmonton Onco Hematology in Ottawa Onco Hematology in Winnipeg Onco Hematology in Quebec City Onco Hematology in Hamilton Onco Hematology in Kitchener Onco Hematology in London Onco Hematology in Halifax Onco Hematology in New York Onco Hematology in Los Angeles Onco Hematology in Chicago Onco Hematology in Houston

Onco Hematology clinical trials

Recruiting onco hematology studies right now

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

ICOPE Program Feasibility in the Management of Myeloma Patients

Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)

Also recruiting in Europe

A multi-center phase III randomized study comparing continuous versus fixed duration therapy with Daratumumab, Lenalidomide, and Dexamethasone for relapsed multiple myeloma (CONFIRM)

Onco Hematology trials by city

Other conditions